Peter Olagunju

Chief Operating Officer at TCR2 THERAPEUTICS INC.

Health Technology

Consumer Services

Profile

Peter Olagunju is currently the Chief Operating Officer at TCR2 Therapeutics, Inc. He previously worked as the Head-Quality at Dendreon Corp.
and ZymoGenetics, Inc. From 2015 to 2020, he served as the Vice President-Global Patient Operations at bluebird bio, Inc. and from 2020 to 2021, he was the Senior Vice President-Technical Operations at FerGene, Inc. Mr. Olagunju holds an MBA from the University of Washington and an undergraduate degree from the University of Illinois At Urbana–Champaign.

Peter Olagunju active positions

Companies	Position	Start
TCR2 THERAPEUTICS INC.	Chief Operating Officer	30/12/2022

All active positions of Peter Olagunju

Former positions of Peter Olagunju

Companies	Position	End
FerGene, Inc. FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer	Corporate Officer/Principal	30/06/2021
GENETIX BIOTHERAPEUTICS, INC.	Corporate Officer/Principal	29/02/2020
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs	Corporate Officer/Principal	-
DENDREON CORPORATION	Corporate Officer/Principal	-

See the detail of Peter Olagunju's experience

Training of Peter Olagunju

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Olagunju's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Dendreon Corp. Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer	Health Technology
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs	Health Technology
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
bluebird bio, Inc. bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells	Health Technology
TCR2 Therapeutics, Inc. TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy	Health Technology
University of Illinois At Urbana–Champaign University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
FerGene, Inc. FerGene, Inc. BiotechnologyHealth Technology Develops gene therapies for the treatment of unresponsive non-muscle invasive bladder cancer	Health Technology